Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what’s new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider’s guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Pfizer CEO Albert Bourla. Photo: “Axios on HBO”
Pfizer CEO Albert Bourla tells “Axios on HBO” that he recently received his first of two doses of the company’s coronavirus vaccine.
Why it matters: Bourla told CNBC in December that company polling found that one of the most effective ways to increase confidence in the vaccine was to have the CEO take it.
- However, Bourla waited until it was his turn in line to receive his shot, and told “Axios on HBO” that he now feels “liberated.”
The big picture: Bourla said he’d advise a family member to get any vaccine offered to them, even those that aren’t as effective against symptomatic disease as the Pfizer shot.
- “This is a pandemic. The vaccines that are approved by the FDA are all vaccines that are meeting the threshold,” he said.
- “If it was the case, can I get a vaccine now — any vaccine now — or a vaccine that I prefer two months later, I would go with whatever I can get now.”
The backstory: Pfizer and Moderna’s coronavirus vaccines, which used mRNA, are upwards of 90% effective against any symptomatic disease.
- Johnson & Johnson’s recently-authorized, one-shot vaccine appears to be significantly less effective against symptomatic disease, but equally as good at preventing hospitalization and death.
Comments
Post a Comment